Dr Harsh Vardhan Inaugurates Second Meeting of Interim Board of CEPI

Published On 2016-12-18 04:23 GMT   |   Update On 2016-12-18 04:23 GMT
Advertisement
The Department of Biotechnology (DBT), Ministry of Science & Technology, Government of India is partnering in the Coalition for Epidemic Preparedness and Innovations (CEPI), a new global alliance between governments, industries, academia, philanthropy, inter-governmental institutions, the World Health Organization, and civil society. The DBT hosted the Second Meeting of the Interim Board of CEPI at New Delhi. The meeting focused on identifying disease priorities, future strategy and setting of Permanent Secretariat for CEPI.
Advertisement


Dr. Harsh Vardhan, Minister for Science & Technology and Earth Sciences inaugurated the event in presence of all the stakeholders of CEPI and senior officials of Departments/Ministries concerned viz. Department of Biotechnology, Ministry of External Affairs, DRDO, Ministry of Health & Family Welfare, Department of Pharmaceuticals, DCGI, etc.


The meeting was attended by Board members from countries in Asia, Africa, Europe, South and North America as well as civil society organizations including Medecins Sans Frontiers as well as the World Health Organization. The structure of CEPI was laid on August 31, 2016 in London and there is an interim Board currently chaired by Prof. K. VijayRaghavan, Secretary DBT. It is the highest decision making body of CEPI, and has supreme decision-making authority for all funding, policy, and product development aspects of CEPIs operations. The scientific input to the Board is provided by a Scientific Advisory Council (SAC) where Indian scientists are members and the joint coordinating group (JCG) is the co-ordination mechanism between CEPI and stakeholders including the vaccine companies.The CEPI aim to finance and coordinate the development of new vaccines to prevent and contain infectious disease epidemics. CEPI is currently being steered by five founding partners. They are: Department of Biotechnology, Ministry of Science & Technology, GOI; Government of Norway; Wellcome Trust; Bill & Melinda Gates Foundation; and World Economic Forum.


ndias participation in CEPI would provide the opportunity to leverage vaccine development capacities in India, access to vaccines as and when needed, protection of our population and boost our ability to have a competitive vaccine industry.



Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News